← Home / XTL BIOPHARMACEUTICALS LTD (XTLB)
Stock Analysis

XTL BIOPHARMACEUTICALS LTD (XTLB)

XTLB
XTLB · Healthcare • Biotechnology
2.58 -0.77%
Track XTLB in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when XTLB price is:
52W Range Position
8%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-26 21:17 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and structural levels before acting.
⚖️
✓
Fundamentals
Negative / Pressured / Strong
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
2.50
↗
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
What's Driving XTLB?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Profitability is negative. Cash generation is pressured. Balance-sheet quality is strong.
⚠️ Key risk remains
losing 2.50 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
43.1
Price Chart
XTLB — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-25
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$6.5M
Company size
EV
$6.4M
Debt-adjusted value
EV/EBIT
-2.9
Not meaningful
P/FCF
-3.0
Not meaningful
FCF Yield
-32.80%
Cash return
Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Mixed
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
451,000
≈ Mixed
📈 Net Income
-1.03M
↘ Negative
🧮 EPS (Basic)
-0.00
↘ Negative
XTL BIOPHARMACEUTICALS LTD
Healthcare • Biotechnology
You Might Also Like